Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma

Treatment resistance is observed in all advanced cancers. Colorectal cancer (CRC) presenting as colorectal adenocarcinoma (COAD) is the second leading cause of cancer deaths worldwide. Multimodality treatment includes surgery, chemotherapy, and targeted therapies with selective utilization of immuno...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kshama Gupta, Jeremy C. Jones, Virginea De Araujo Farias, Yuri Mackeyev, Pankaj K. Singh, Alfredo Quiñones-Hinojosa, Sunil Krishnan
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2022-05-01
Collection:Frontiers in Oncology
Sujets:
KRAS
DDR1
BCR-ABL1
COAD
GBM
chemoradioresistance
Accès en ligne:https://www.frontiersin.org/articles/10.3389/fonc.2022.840241/full
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires